By David Pineles, MD
Peer Reviewed
With the implementation of the ACC/AHA guidelines on assessment of cardiovascular risk, HMG-CoA reductase inhibitors, commonly known as statins, will become one of the most prescribed medications in history [1]. Dr. John Ioadnnidis, in an article published …
By David Rhee MD, Greg Katz MD, Marty Fried MD, Shreya P. Trivedi MD || Illustration by Michael Natter MD || Audio Editing …
By Hannah Friedman
Peer Reviewed
It is a commonly seen scenario on the wards: a patient with a past medical history of heart failure and stage 4 chronic kidney disease presents with progressive …
By Dixon Yang, MD
Peer ReviewedÂ
AbstractÂ
Atrial fibrillation (AF) is a common arrhythmia, especially in the elderly, and is often asymptomatic. However, absence of symptoms does not confer better prognosis. Many patients with AF …
By Monil Shah, MD and Arun Manmadhan, MD
Peer Reviewed
A 64-year old male with a history of hypertension, dyslipidemia, and uncontrolled diabetes is brought to the emergency room with new …
By Helen Ma, MD
Peer Reviewed
Our new Spotlight series uses case vignettes to explore diagnosis, pathophysiology, and management of a wide variety of diseases seen in the outpatient and inpatient settings. …
By Maxine Wallis Stachel, MD
Peer Reviewed
The Scale of the Problem
Despite decades of rigorous data collection, drug research, patient education and evidence-based practice, ischemic heart disease (IHD) and congestive heart failure (CHF) remain …
By Omotayo Arowojolu
Peer Reviewed
Approximately 32% of American adults have high blood pressure (>140/90 mmHg),1 or hypertension, and only 54% of these individuals have well-controlled hypertension.2,3 Hypertension costs $48.6 billion each year …